Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CXCR1 | P25024 | 11/20 | 0.53 |
| ▸ | CXCR2 | P25025 | 11/20 | 0.53 |
| ▸ | CXCR3 | P49682 | 2/20 | 0.53 |
| ▸ | CCR6 | P51684 | 2/20 | 0.53 |
| ▸ | CCR4 | P51679 | 1/20 | 0.51 |
| ▸ | CNR1 | P21554 | 1/20 | 0.46 |
| ▸ | CNR2 | P34972 | 1/20 | 0.46 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.45 |
| ▸ | LOX | P28300 | 1/20 | 0.43 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12261967 | 0.84 | CXCR1 (0.47) | CXCR1CXCR2CXCR3CCR6CCR4 | |
| SCHEMBL14904732 | 0.84 | CXCR1 (0.47) | CXCR1CXCR2CXCR3CCR6CCR4 | |
| SCHEMBL12312383 | 0.84 | CXCR1 (0.47) | CXCR1CXCR2CXCR3CCR6CCR4 | |
| SCHEMBL14904744 | 0.83 | CXCR2 (0.62) | CXCR1CXCR2CXCR3CCR6CCR4 | |
| SCHEMBL14904733 | 0.83 | CXCR2 (0.62) | CXCR1CXCR2CXCR3CCR6CCR4 | |
| SCHEMBL18314630 | 0.83 | CXCR2 (0.62) | CXCR1CXCR2CXCR3CCR6CCR4 | |
| SCHEMBL16144705 | 0.81 | MAPT (0.48) | CXCR1CXCR2CXCR3CCR6CCR4 | |
| SCHEMBL14904735 | 0.81 | MAPT (0.48) | CXCR1CXCR2CXCR3CCR6CCR4 | |
| SCHEMBL16144713 | 0.81 | MAPT (0.48) | CXCR1CXCR2CXCR3CCR6CCR4 | |
| SCHEMBL31562993 | 0.81 | CNR1 (0.53) | CXCR1CXCR2CXCR3CCR6CNR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9580412-B2 | Disubstituted 3,4-diamino-3-cyclobutene-1,2-dione compounds for use in the treatment of chemokine-mediated diseases | GALDERMA RESEARCH & DEVELOPMENT (FR) | 2017-02-28 | — | — | US | disclosed |